Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobetasol, ATC D07AD01 für die Zeit 01.12.2023 - 30.11.2025
Original language: German
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Buyer
- DAK-Gesundheit
- Winners
- acis Arzneimittel GmbH, Dermapharm AG, GlaxoSmithKline GmbH & Co. KG, Pierre Fabre Pharma GmbH
- Contract value
- no value published
- Bids received
- 8
- Published
- 26 Sept 2025
- Region
- Hamburg